Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study

Abstract

ACE2 and Mpro in the pathology of SARS-CoV-2 show great potential in developing COVID-19 drugs as therapeutic targets, due to their roles as the “gate” of viral entry and viral reproduction. Of the many potential compounds for ACE2 and Mpro inhibition, α-mangostin is a promising candidate. Unfortunately, the potential of α-mangostin as a secondary metabolite with the anti-SARS-CoV-2 activity is hindered due to its low solubility in water. Other xanthone isolates, which also possess the xanthone core structure like α-mangostin, are predicted to be potential alternatives to α-mangostin in COVID-19 treatment, addressing the low drug-likeness of α-mangostin. This study aims to assess the potential of xanthone derivative compounds in the pericarp of mangosteen (Garcinia mangostana L.) through computational study. The study was conducted through screening activity using molecular docking study, drug-likeness prediction using Lipinski’s rule of five filtration, pharmacokinetic and toxicity prediction to evaluate the safety profile, and molecular dynamic study to evaluate the stability of formed interactions. The research results showed that there were 11 compounds with high potential to inhibit ACE2 and 12 compounds to inhibit Mpro. However, only garcinone B, in addition to being indicated as active, also possesses a drug-likeness, pharmacokinetic, and toxicity profile that was suitable. The molecular dynamic study exhibited proper stability interaction between garcinone B with ACE2 and Mpro. Therefore, garcinone B, as a xanthone derivative isolate compound, has promising potential for further study as a COVID-19 treatment as an ACE2 and Mpro inhibitor.

Nanosuspension-Based Drug Delivery Systems for Topical Applications

“…To assess density accurately at a specific temperature, it is advisable to employ a well-mixed and uniform formulation and utilize precision hydrometers for these measurements. 2 , 17 , 52 …”

“…This scrutiny is vital due to the pivotal role that preservation plays in the context of cutaneous preparations. 2 , 102 …”

“… 1 Regrettably, a considerable proportion of these promising medications grapple with the challenge of low water solubility, with approximately 40% of drugs in the developmental pipeline encountering solubility issues. 2 , 3 High-throughput screening techniques have contributed to the identification of an increasing number of drugs exhibiting limited water solubility.…”

“… 10 The effectiveness of these approaches hinges on the specific chemical characteristics exhibited by molecules, encompassing factors such as their solubility in different organic solvents and distinctive attributes related to molecular size or configuration, such as molecules designed for incorporation into cyclodextrin ring structures. 2 , 11 Undoubtedly, a more rational approach would involve the implementation of a “universal formulation approach” that can be applied to a wide range of molecules.…”

Alginate and Chitosan-Based Hydrogel Enhance Antibacterial Agent Activity on Topical Application

“…It can be applied to both secondary metabolites and synthetic chemical compounds. 88 Researchers have also found this base to be a relevant choice for developing the delivery of marketed active pharmaceutical ingredients, including tetracycline, tobramycin, and vancomycin. One study demonstrates the applicability of alginate-chitosan-based hydrogel in delivering the active ingredient extract, namely Solanum nigrum L. leaf extract.…”